Audited Financial Results along with Statement of Assets & Liabilities and the Statement of Cash Flow and Auditors Report of the Company for the Quarter and Financial Year ended March 31, 2026.
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 1.6 pts less than Nifty Microcap 250 and 1.7 pts less than its Trading & Distributors peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
Saptak Chem and Business Limited reported zero revenue from operations for FY 2025-26, with a net loss of Rs 30.21 Lakhs compared to a loss of Rs 8.62 Lakhs in the previous year. The company had other income of just Rs 0.26 Lakhs for the year. The balance sheet shows negative equity of Rs 150.89 Lakhs (improved from Rs 225.68 Lakhs negative), primarily due to a share issue of Rs 105 Lakhs during the year. Cash position improved to Rs 25.32 Lakhs from Rs 0.82 Lakhs, helped by financing activities. The company incurred negative operating cash flows of Rs 109.08 Lakhs. Related party transactions included Rs 1.90 Lakhs remuneration to the Company Secretary and Rs 0.27 Lakhs loan to the Managing Director.
The stock shows severe financial stress with zero revenue, mounting losses, negative equity of Rs 150.89 Lakhs, and heavy reliance on share issuances to stay afloat. Shareholders should be cautious as the company's ability to continue as a going concern without operational income is questionable.